Lifecore Accounts Payable from 2010 to 2025
| LFCR Stock | 6.09 0.15 2.53% |
Accounts Payable | First Reported 1996-02-29 | Previous Quarter 18 M | Current Value 15 M | Quarterly Volatility 14.3 M |
Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.4 M, Interest Expense of 21.8 M or Total Revenue of 140.1 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.74. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.
Lifecore | Accounts Payable |
Latest Lifecore Biomedical's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Lifecore Biomedical over the last few years. An accounting item on the balance sheet that represents Lifecore Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lifecore Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Lifecore Biomedical's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifecore Biomedical's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
Lifecore Accounts Payable Regression Statistics
| Arithmetic Mean | 26,411,604 | |
| Geometric Mean | 20,153,383 | |
| Coefficient Of Variation | 52.47 | |
| Mean Deviation | 10,711,346 | |
| Median | 25,868,000 | |
| Standard Deviation | 13,858,293 | |
| Sample Variance | 192.1T | |
| Range | 53.5M | |
| R-Value | (0.1) | |
| Mean Square Error | 203.8T | |
| R-Squared | 0.01 | |
| Significance | 0.72 | |
| Slope | (287,322) | |
| Total Sum of Squares | 2880.8T |
Lifecore Accounts Payable History
About Lifecore Biomedical Financial Statements
Lifecore Biomedical shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 18.8 M | 22.1 M |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.